NN 9927Alternative Names: NN-9927; OG987SC
Latest Information Update: 24 Apr 2016
At a glance
- Originator Novo Nordisk
- Class Antihyperglycaemics; Glucagon-like peptides
- Mechanism of Action Glucagon like peptide 1 receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus